These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19229802)

  • 61. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
    Freedman RR; Girgis R; Mayes MD
    Lancet; 1999 Aug; 354(9180):739. PubMed ID: 10475187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Freezing fingers syndrome, primary and secondary Raynaud's phenomenon: characteristic features with hand thermography.
    Chlebicka I; Matusiak Ł; Maj J; Baran E; Szepietowski JC
    Acta Derm Venereol; 2013 Jul; 93(4):428-32. PubMed ID: 23314682
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Raynaud's phenomenon].
    Sprynger M
    Rev Med Liege; 2004 Jun; 59(6):378-84. PubMed ID: 15346976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon.
    Lau CS; Bridges AB; Muir A; Scott N; Bancroft A; Belch JJ
    Br J Rheumatol; 1992 Jun; 31(6):375-80. PubMed ID: 1596699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
    Lau CS; Belch JJ; Madhok R; Cappell H; Herrick A; Jayson M; Thompson JM
    Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma eicosanoids, platelet function and cold sensitivity.
    Wilkinson D; Vowden P; Gilks L; Latif AB; Rajah SM; Kester RC
    Br J Surg; 1989 Apr; 76(4):401-5. PubMed ID: 2720355
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blood viscosity and local response to cold in primary Raynaud's phenomenon.
    Jahnsen T; Nielsen SL; Skovborg F
    Lancet; 1977 Nov; 2(8046):1001-2. PubMed ID: 72898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
    Wigley FM; Wise RA; Malamet R; Scott TE
    Arthritis Rheum; 1987 Mar; 30(3):281-6. PubMed ID: 2952125
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud's phenomenon.
    Grossi G; Mariotti A; Di Donato L; Amerio P; Tulli A; Romani GL; Merla A
    Int J Immunopathol Pharmacol; 2010; 23(2):627-32. PubMed ID: 20646358
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Infrared functional imaging applied to Raynaud's phenomenon.
    Merla A; Di Donato L; Di Luzio S; Farina G; Pisarri S; Proietti M; Salsano F; Romani GL
    IEEE Eng Med Biol Mag; 2002; 21(6):73-9. PubMed ID: 12613214
    [No Abstract]   [Full Text] [Related]  

  • 73. Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenonenon and systemic sclerosis.
    Anderson ME; Campbell F; Hollis S; Moore T; Jayson MI; Herrick AL
    Clin Exp Rheumatol; 1999; 17(1):49-54. PubMed ID: 10084032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.
    Sandqvist G; Wollmer P; Scheja A; Wildt M; Hesselstrand R
    Scand J Rheumatol; 2018 May; 47(3):206-209. PubMed ID: 28803485
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.
    Sunderland GT; Belch JJ; Sturrock RD; Forbes CD; McKay AJ
    Clin Rheumatol; 1988 Mar; 7(1):46-9. PubMed ID: 3044673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 77. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
    Freedman RR; Moten M; Migály P; Mayes M
    Arthritis Rheum; 1993 May; 36(5):685-90. PubMed ID: 8387786
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.
    Gigante A; Margiotta D; Navarini L; Liberatori M; Barbano B; Tubani L; Afeltra A; Rosato E
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):24-27. PubMed ID: 29787366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decreased oesophageal blood flow in patients with Raynaud's phenomenon.
    Belch JJ; Land D; Park RH; McKillop JH; MacKenzie JF
    Br J Rheumatol; 1988 Dec; 27(6):426-30. PubMed ID: 3203185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship of age and body mass index to skin temperature and skin perfusion in primary Raynaud's phenomenon.
    Giurgea GA; Mlekusch W; Charwat-Resl S; Mueller M; Hammer A; Gschwandtner ME; Koppensteiner R; Schlager O
    Arthritis Rheumatol; 2015 Jan; 67(1):238-42. PubMed ID: 25330753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.